anticholinergic medication

Sharing news within Among Doctors network is a way of appraising and curating evidence, contributing to the dissemination of knowledge with your trusted network. Let’s have a look at what news have been shared lately:

• Diet, nutrition, physical activity and stomach cancer
  The World Cancer Research Fund released a new report on stomach cancer linking for the first time drinking alcohol, eating processed meat and being overweight to an increased risk of developing stomach cancers.
• FDA evaluating study examining use of oral fluconazole in pregnancy
  FDA is evaluating the results of a Danish study that conclude there is a possible increased risk of miscarriage with the use of oral fluconazole for yeast infections.
• Cochrane Systematic Review: A comparison of different antibiotic regimens for the treatment of infective endocarditis
  Limited and very low quality evidence suggested that there were no conclusive differences between antibiotic regimens in terms of cure rates or other relevant clinical outcomes.
• Association between anticholinergic medication and cognition, brain metabolism, and brain atrophy in cognitively normal older adults
  Anticholinergic medication use was linked with risk for future progression to mild cognitive impairment or Alzheimer’s disease.
• Cochrane Systematic Review: Mobile phone-based interventions for smoking cessation
  The current evidence supports a beneficial impact of mobile phone-based smoking cessation interventions on six-month cessation outcomes.
• Exposure to advertisements and electronic cigarette use among US middle and high school students
  The odds of electronic cigarette use increased with greater exposure to electronic cigarette advertising, with Internet advertisements having the strongest effect.